Skip to main content
TVTX filings

Corporate insider profile

Gary A Lyons Filing Activity

Latest reported as Director of Travere Therapeutics, Inc. (TVTX).

Purchase filings
0
Reported companies
1
Net open-market value
-$961,406.00
Latest transaction
Aug 18, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 18, 2026Travere Therapeutics, Inc. (TVTX)DirectorSale10,000$63.28$632,846
Apr 14, 2026Travere Therapeutics, Inc. (TVTX)DirectorSale8,000$41.07$328,560